Skip to main content
. 2016 Jul 26;9(6):823–835. doi: 10.1177/1756283X16658252

Figure 2.

Figure 2.

Plasma ammonia-concentration evolution during the study period in the ornithine phenylacetate and placebo groups.

Data are mean and one-sided standard deviation. Numbers at each timepoint indicate the number of patients with plasma samples analyzed.

FU, follow up.

*p < 0.05, mean ammonia in treated group at 120 hours was significantly lower than placebo group.